Calculation of carcinogenic potency from long-term animal carcinogenesis experiments

Area of Science:

• Toxicology
• Carcinogenesis Research
• Quantitative Risk Assessment

Background:

• Assessing chemical carcinogenicity is crucial for public health.
• Existing methods for quantifying carcinogenic potency can be complex.
• A standardized metric is needed for comparing the cancer-causing potential of different chemicals.

Purpose of the Study:

• To introduce and define a novel index, the tumorigenic dose 50 (TD50), for quantifying carcinogenic potency.
• To establish a method for estimating the TD50 from chronic animal bioassay data.
• To provide a framework for comparing the carcinogenic effects of various chemical agents.

Main Methods:

• Defined the TD50 by analogy with the lethal dose 50 (LD50).
• Utilized life-table methods to account for intercurrent deaths in control and exposed groups.
• Developed nonparametric statistical procedures for TD50 estimation and confidence interval construction.
• Assumed a linear relationship between chemical dose and tumor hazard rate.

Main Results:

• The TD50 provides a direct measure of a chemical's potency in inducing tumors in animal models.
• The proposed methods allow for robust estimation of the TD50 even with complex survival data.
• Confidence intervals can be constructed to indicate the precision of the TD50 estimates.

Conclusions:

• The TD50 is a valuable and interpretable metric for assessing chemical carcinogenic potency.
• This index facilitates standardized comparisons of carcinogenicity across different chemicals.
• The developed statistical methods support the reliable application of the TD50 in toxicological risk assessment.